The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis
Abstract
Methamphetamine (METH) is a drug of abuse that has long been known to damage monoaminergic systems in the mammalian brain. Recent reports have provided conclusive evidence that METH can cause neuropathological changes in the rodent brain via apoptotic mechanisms akin to those reported in various models of neuronal death. The purpose of this review is to provide an interim account for a role of oxygen‐based radicals and the participation of transcription factors and the involvement of cell death genes in METH‐induced neurodegeneration. We discuss data suggesting the participation of endoplasmic reticulum and mitochondria‐mediated activation of caspase‐dependent and ‐independent cascades in the manifestation of METH‐induced apoptosis. Studies that use more comprehensive approaches to gene expression profiling should allow us to draw more instructive molecular portraits of the complex plastic and degenerative effects of this drug.—Cadet, J. L., Jayanthi, S., Deng, X. Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17, 1775–1788 (2003)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Methamphetamine (MA) is a psychostimulant that when used regularly is associated with harms such as injecting and sexual risk-taking behaviour, symptoms of mental ill health (eg, psychosis, aggression, depression and/or anxiety), psychomotor, social and cognitive impairment, criminal activity and sometimes death caused by overdose.1–7”
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K. N., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,913
Caspases: the executioners of apoptosis
Cohen, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,737
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Peroxynitrite oxidation of sulfhydryls.
Radí, R., Beckman, J. S., Bush, K., & Freeman, B. Α. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,492
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,125
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H. E., Stevens, J. L., & Ron, D. (1998) · Genes & Development · doi:10.1101/gad.12.7.982 · Cited by 2,039
McCullough, K. D., Martindale, J. L., Klotz, L., Aw, T. Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,945
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35053570 · Cited by 1,893
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555 · cited 2×
“JNK activation can be accomplished by the upstream kinases MKK4 (135) or MKK7 (136).”
BackgroundOrganelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,455
Superoxide Anion Radical (O·̄2), Superoxide Dismutases, and Related Matters
Fridovich, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18515 · Cited by 1,337
Cross-Talk between Two Cysteine Protease Families
Nakagawa, T., & Yuan, J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.887 · Cited by 1,197
Role of poly(ADP-ribose) formation in DNA repair
Satoh, M. S., & Lindahl, T. L. (1992) · Nature · doi:10.1038/356356a0 · Cited by 1,196
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168
Ron, D., & Habener, J. F. (1992) · Genes & Development · doi:10.1101/gad.6.3.439 · Cited by 1,156
A Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation
Schuman, E. M., & Madison, D. V. (1991) · Science · doi:10.1126/science.1720572 · Cited by 1,135
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.
Susín, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, É., Geuskens, M., & Kroemer, G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1331 · Cited by 1,133
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
Dawson, V., Dawson, T., Bartley, D., Uhl, G. R., & Snyder, S. H. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02651.1993 · Cited by 1,014
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., Matsuda, H., & Tsujimoto, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14681 · Cited by 942
Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
Korsmeyer, S. J., Shutter, J. R., Novack, D. V., Merry, D. E., & Oltvai, Z. N. (1993) · PubMed · Cited by 865
Mitochondrial permeability transition is a central coordinating event of apoptosis.
Marchetti, P., Castedo, M., Susín, S. A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., & Kroemer, G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1155 · Cited by 851
Patil, C., & Walter, P. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00219-2 · Cited by 779
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Karin, M., & Hunter, T. R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00151-5 · Cited by 747
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G. D., Anthony, R. M., Schmunk, G. A., Shannak, K. S., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
Psychomotor stimulant addiction: a neural systems perspective
Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700
Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688
Marzo, I., Brenner, C., Zamzami, N., Susín, S. A., Beutner, G., Brdiczka, D. G., Rémy, R., Xie, Z.-H., Reed, J. C., & Kroemer, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1261 · Cited by 684
Pleiotropic effects of a null mutation in the c-fos proto-oncogene
Johnson, R. S., Spiegelman, B. M., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90592-z · Cited by 636
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602 · cited 1×
“PET studies have revealed substantial loss of striatal dopamine transporters (DAT) in METH users who have been abstinent for an average of 1–3 years (20, 21).”
BackgroundThe chemistry of DNA damage from nitric oxide and peroxynitrite
Burney, S., Caulfield, J. L., Niles, J. C., Wishnok, J. S., & Tannenbaum, S. R. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00006-8 · Cited by 556
Davidson, C., Gow, A. J., Lee, T. H., & Ellinwood, E. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00054-6 · Cited by 518
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499
Self-citationRicaurte, G. A., Schuster, C. R., & Seiden, L. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90952-x · Cited by 490
Jänicke, R. U., Ng, P., Sprengart, M. L., & Porter, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15540 · Cited by 486
Mitochondria, the killer organelles and their weapons
Ravagnan, L., Roumier, T., & Kroemer, G. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10111 · Cited by 483
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
The double-edged role of nitric oxide in brain function and superoxide-mediated injury.
Beckman, J. S. (1991) · PubMed · Cited by 463
LaVoie, M. J., & Hastings, T. G. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 449
Cubells, J. F., Rayport, S., Rajendran, G., & Sulzer, D. L. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 446
Hotchkiss, A. J., & Gibb, J. W. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32165-8 · Cited by 443
Massaro, E. J. (2001) · Humana Press eBooks · doi:10.1385/1592591329 · Cited by 433
Boyd, J. M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S. E., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T., & Lutz, R. J. (1995) · PubMed · Cited by 429
Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer, J. F., Davies, D. L., Schmued, L. C., Broening, H. W., Newport, G. D., Slikker, W., & Holson, R. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38650-7 · Cited by 412
Ramana, C. V., Boldogh, I. R., Izumi, T., & MITRA, S. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5061 · Cited by 409
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.
O'Callaghan, J. P., & Miller, D. B. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22433-8 · Cited by 409
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00463-2 · Cited by 404
Superoxide Reacts with Nitric Oxide to Nitrate Tyrosine at Physiological pH via Peroxynitrite
Reiter, C. D., Teng, R., & Beckman, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910433199 · Cited by 385
Serotonin content of the brain stem nuclei in the rat
Palkovits, M., Brownstein, M., & Saavedra, J. M. (1974) · Brain Research · doi:10.1016/0006-8993(74)90688-x · Cited by 384
Gu, H., Wall, S. C., & Rudnick, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37256-3 · Cited by 379
Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH 2 -terminal kinase
Tournier, C., Whitmarsh, A. J., Cavanagh, J., Barrett, T., & Davis, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7337 · Cited by 377
Murachi, T., Tanaka, K., Hatanaka, M., & Murakami, T. (1981) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(81)90026-1 · Cited by 374
Evidence for long-term neurotoxicity associated with methamphetamine abuse
Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373
Kramer, J. C. (1967) · JAMA · doi:10.1001/jama.201.5.305 · Cited by 368
Watson, A., Eilers, A., Lallemand, D., Kyriakis, J. M., Rubin, L. L., & Ham, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00751.1998 · Cited by 360
Growth factors regulate the survival and fate of cells derived from human neurospheres
Caldwell, M. A., He, X., Wilkie, N. M., Pollack, S., Marshall, G. R., Wafford, K. A., & Svendsen, C. N. (2001) · Nature Biotechnology · doi:10.1038/88158 · Cited by 343
Herdegen, T., Claret, F.-X., Kallunki, T., Martín-Villalba, A., Winter, C., Hunter, T., & Karin, M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05124.1998 · Cited by 327
Cognitive Impairment in Individuals Currently Using Methamphetamine
Simon, S. L., Domier, C. P., Carnell, J., Brethen, P., Rawson, R. A., & Ling, W. W. (2000) · American Journal on Addictions · doi:10.1080/10550490050148053 · Cited by 322
Bax and Bak Promote Apoptosis by Modulating Endoplasmic Reticular and Mitochondrial Ca2+ Stores
Nutt, L. K., Pataer, A., Pahler, J., Fang, B., Roth, J. A., McConkey, D. J., & Swisher, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106817200 · Cited by 320
Bad Is a BH3 Domain-Containing Protein That Forms an Inactivating Dimer with Bcl-X L
Kelekar, A., Chang, B. S., Harlan, J. E., Fesik, S. W., & Thompson, C. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7040 · Cited by 273
Methamphetamine-induced neuronal damage: A possible role for free radicals
Vito, M. J. D., & Wagner, G. C. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90130-5 · Cited by 270
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Src and Cas Mediate JNK Activation but Not ERK1/2 and p38 Kinases by Reactive Oxygen Species
Yoshizumi, M., Abe, J., Haendeler, J., Huang, Q., & Berk, B. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11706 · Cited by 263
Cadet, J. L., Sheng, P., All, S., Rothman, R. B., Carlson, E. J., & Epstein, C. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010380.x · Cited by 263
Self-citationMiller, D. B., & O'Callaghan, J. P. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 261
Fukunaga, K., & Miyamoto, E. (1998) · Molecular Neurobiology · doi:10.1007/bf02740604 · Cited by 256
Albers, D. S., & Sonsalla, P. K. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12160-5 · Cited by 256
A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses
Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y., & Nishida, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7045 · Cited by 250
Higher Cortical and Lower Subcortical Metabolism in Detoxified Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y., Wong, C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.383 · Cited by 249
Fumagalli, F., Gainetdinov, R. R., Wang, Y., Valenzano, K. J., Miller, G. W., & Caron, M. G. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02424.1999 · Cited by 241
Nucleotide excision repair: From E. coli to man
Petit, C. R., & Sancar, A. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80034-0 · Cited by 237
Rapid and Reversible Effects of Methamphetamine on Dopamine Transporters
Fleckenstein, A. E., Metzger, R. R., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36858-2 · Cited by 233
Excitotoxicity, free radicals, and cell membrane changes
Dugan, L. L., & Choi, D. W. (1994) · Annals of Neurology · doi:10.1002/ana.410350707 · Cited by 226
Seiden, L. S., & Vosmer, G. L. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90125-4 · Cited by 221
Kogan, F. J., Nichols, W. K., & Gibb, J. W. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90090-x · Cited by 217
Villemagne, V. L., Yuan, J., Wong, D. F., Dannals, R. F., Hatzidimitriou, G., Mathews, W. B., Ravert, H. T., Musachio, J. L., McCann, U. D., & Ricaurte, G. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00419.1998 · Cited by 211
Mashima, T., Naito, M., & Tsuruo, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202558 · Cited by 208
Long-term effects of chronic methamphetamine administration in rhesus monkeys
Woolverton, W. L., Ricaurte, G. A., Forno, L. S., & Seiden, L. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)91279-1 · Cited by 205
Giovanni, A., Liang, L., Hastings, T. G., & Zigmond, M. J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041819.x · Cited by 202
Deng, X., Wang, Y., Chou, J., & Cadet, J. L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00184-x · Cited by 200
Self-citationRoles of Reactive Oxygen Species: Signaling and Regulation of Cellular Functions
Gamaley, I. A., & Klyubin, I. V. (1999) · International review of cytology · doi:10.1016/s0074-7696(08)61568-5 · Cited by 198
Base excision repair in a network of defence and tolerance
Nilsen, H. L., & Krokan, H. E. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.987 · Cited by 197
Minden, A., Lin, A., Smeal, T., Dérijard, B., Cobb, M., Davis, R., & Karin, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6683 · Cited by 195
Fos is an essential component of the mammalian UV response.
Schreiber, M., Baumann, B., Cotten, M. L., Angel, P. E., & Wagner, E. F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00218.x · Cited by 193
Sonsalla, P. K., Riordan, D. E., & Heikkila, R. E. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22956-1 · Cited by 184
Amphetamines induce apoptosis and regulation of bcl‐x splice variants in neocortical neurons
Stumm, G., Schlegel, J., Schäfer, T., Würz, C., Mennel, H. D., Krieg, J. C., & Vedder, H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1065 · Cited by 178
Tabner, B. S. P. B. J., Turnbull, B. S. P. S., El-Agnaf, B. S. P. O. M. A., & Allsop, B. S. P. D. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394822 · Cited by 174
Mechanisms controlling cellular suicide: role of Bcl-2 and caspases
Allen, R. T., Cluck, M. W., & Agrawal, D. K. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050171 · Cited by 166
Jayanthi, S., Deng, X., BORDELON, M., McCoy, M. T., & Cadet, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.01-0025com · Cited by 165
Self-citationLocalization of pontine PGO wave generation sites and their anatomical projections in the rat
Datta, S., Siwek, D. F., Patterson, E. H., & Cipolloni, P. B. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199812)30:4 · Cited by 162
Methamphetamine-related stroke: four cases
Perez, J. A., Arsura, E. L., & Strategos, S. (1999) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(99)00009-8 · Cited by 162
Bokemeyer, D., Sorokin, A., Yan, M., Ahn, N. G., Templeton, D. J., & Dunn, M. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.639 · Cited by 157
Induction of beta-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells.
Fornace, A. J., Zmudzka, B. Z., Hollander, M. C., & Wilson, S. H. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.851 · Cited by 155
Kinetics and Block of Dopamine Uptake in Synaptosomes from Rat Caudate Nucleus
Krueger, B. K. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08847.x · Cited by 155
Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules
Utz, P. J., & Anderson, P. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400696 · Cited by 155
Amphetamine toxicity: Experience with 127 cases
Derlet, R. W., Rice, P., Horowitz, B. Z., & Lord, R. V. (1989) · Journal of Emergency Medicine · doi:10.1016/0736-4679(89)90263-1 · Cited by 154
Gluck, M. R., Moy, L. Y., Jayatilleke, E., Hogan, K. A., Manzino, L., & Sonsalla, P. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00549.x · Cited by 153
Paschen, W. (2001) · Cell Calcium · doi:10.1054/ceca.2000.0162 · Cited by 151
Psychological morbidity and route of administration among amphetamine users in Sydney, Australia
Hall, W., Hando, J., Darke, S. G., & Ross, J. E. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.9118110.x · Cited by 147
Sonsalla, P. K., Gibb, J. W., & Hanson, G. R. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24344-0 · Cited by 147
Itzhak, Y., Gandia, C. E., Huang, P. L., & Ali, S. F. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37339-2 · Cited by 147
Jayanthi, S., Ladenheim, B., & Cadet, J. L. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08224.x · Cited by 143
Self-citationMICHEL, R., & Adams, A. P. (1979) · Anaesthesia · doi:10.1111/j.1365-2044.1979.tb06250.x · Cited by 142
Chan, P., Monte, D. A. D., Luo, J. J., DeLanney, L. E., Irwin, I., & Langston, J. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062484.x · Cited by 141
Fleckenstein, A. E., Haughey, H. M., Metzger, R. R., Kokoshka, J. M., Riddle, E. L., Hanson, J. E., Gibb, J. W., & Hanson, G. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00588-9 · Cited by 136
Friedman, S. D., Castañeda, E., & Hodge, G. K. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00066-5 · Cited by 136
Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate
Wagner, C., Ricaurte, G. A., Johanson, C. E., Schuster, C. R., & Seiden, L. S. (1980) · Neurology · doi:10.1212/wnl.30.5.547 · Cited by 134
Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants
Schmued, L. C., & Bowyer, J. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00173-x · Cited by 131
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131
Death in amphetamine users: causes and rates.
Kalant, H., & Kalant, O. J. (1975) · PubMed Central · Cited by 129
Harvey, D. C., Laćan, G., Tanious, S. P., & Melega, W. P. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02439-2 · Cited by 127
Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humansa
Ricaurte, G. A., & McCann, U. D. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24586.x · Cited by 126
Melega, W. P., Raleigh, M. J., Stout, D. B., Laćan, G., Huang, S.-C., & Phelps, M. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00548-9 · Cited by 126
Marek, G. J., Vosmer, G. L., & Seiden, L. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90467-p · Cited by 124
Deng, X., Cai, N.-S., McCoy, M. T., Chen, W., Trush, M. A., & Cadet, J. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00034-5 · Cited by 121
Self-citationUjike, H., Takaki, M., Kodama, M., & Kuroda, S. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04151.x · Cited by 121
Jicha, G. A., Berenfeld, B., & Davies, P. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 119
Pu, C., & Vorhees, C. V. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90201-k · Cited by 119
Zubieta, J., Koeppe, R. A., Frey, K. A., Kilbourn, M. R., Mangner, T. J., Foster, N. L., & Kuhl, D. E. (2001) · Synapse · doi:10.1002/1098-2396(20010315)39:4 · Cited by 118
Self-citationHirata, H., Ladenheim, B., Carlson, E. J., Epstein, C. J., & Cadet, J. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01502-7 · Cited by 117
Self-citationImam, S. Z., Newport, G. D., Itzhak, Y., Cadet, J. L., Islam, F., Slikker, W., & Ali, S. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00029.x · Cited by 113
Self-citationNull Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity
Deng, X., Ladenheim, B., Tsao, L.-I., & Cadet, J. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-10107.1999 · Cited by 113
Self-citationFukumura, M., Cappon, G. D., Pu, C., Broening, H. W., & Vorhees, C. V. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00656-8 · Cited by 110
Farfel, G. M., & Seiden, L. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24505-0 · Cited by 109
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109
Long-Term Changes in Basal Ganglia Function after a Neurotoxic Regimen of Methamphetamine
Chapman, D. E., Hanson, G. R., Kesner, R. P., & Keefe, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38769-5 · Cited by 109
Frey, K. A., Kilbourn, M. R., & Robinson, T. E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01152-7 · Cited by 104
Cadet, J. L., Jayanthi, S., McCoy, M. T., Vawter, M. P., & Ladenheim, B. (2001) · Synapse · doi:10.1002/syn.1058 · Cited by 103
Self-citationNature of methamphetamine-induced rapid and reversible changes in dopamine transporters
Kokoshka, J. M., Vaughan, R. A., Hanson, G. R., & Fleckenstein, A. E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00741-9 · Cited by 102
Koch, R., & Barish, M. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02585.1994 · Cited by 101
Figueredo-Cardenas, G., Harris, C. L., Anderson, K. D., & Reiner, A. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6724 · Cited by 100
Mulholland, G. K., Wieland, D. M., Kilbourn, M. R., Frey, K. A., Sherman, P. S., Carey, J. E., & Kuhl, D. E. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199811)30:3 · Cited by 100
Immunocytochemical evidence for methamphetamine‐induced serotonergic axon loss in the rat brain
Axt, K. J., & Molliver, M. E. (1991) · Synapse · doi:10.1002/syn.890090405 · Cited by 100
Mechanisms of Bcl-2 family protein function and dysfunction in health and disease.
Reed, J. C. (1996) · PubMed · Cited by 99
Cass, W. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08132.1996 · Cited by 99
Cass, W. A., & Manning, M. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07653.1999 · Cited by 98
Yui, K., Goto, K., Ikemoto, S., Ishiguro, T., Angrist, B., Duncan, G. E., Sheitman, B., Lieberman, J. A., Bracha, S., & Ali, S. F. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000575 · Cited by 95
Steranka, L. R., & Sanders‐Bush, E. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90351-9 · Cited by 95
Bakhit, C., Morgan, M. E., Peat, M., & Gibb, J. W. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90053-8 · Cited by 94
Dopamine-glutamate interactions in methamphetaminc-induced neurotoxicity
Marshall, J. F., O'Dell, S. J., & Weihmuller, F. B. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245234 · Cited by 93
Clinical manifestations and prognostic features of acute methamphetamine intoxication.
Lan, K. C., Lin, Y., Yu, F. C., Lin, C. S., & Chu, P. (1998) · PubMed · Cited by 91
Deng, X., & Cadet, J. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00169-8 · Cited by 90
Self-citationJayanthi, S., Ladenheim, B., Andrews, A. M., & Cadet, J. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00698-8 · Cited by 90
Self-citationSonsalla, P. K., & Heikkila, R. E. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90054-1 · Cited by 86
Protein Phosphorylation Cascades Associated with Methamphetamine‐induced Glial Activation
Hebert, M. A., & O'Callaghan, J. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05200.x · Cited by 84
Fleckenstein, A. E., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37016-8 · Cited by 84
Vega, W. A., Gil, A. G., Warheit, G. J., Apospori, E., & Zimmerman, R. S. (1993) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.1993.tb00375.x · Cited by 84
Fetal and Infant Deaths Associated with Maternal Methamphetamine Abuse
Stewart, J. L., & Meeker, J. E. (1997) · Journal of Analytical Toxicology · doi:10.1093/jat/21.6.515 · Cited by 82
Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.
Wagner, G. C., Carelli, R. M., & Jarvis, M. F. (1985) · PubMed · Cited by 80
Kaina, B., Haas, S., & Kappes, H. (1997) · PubMed · Cited by 75
Cappon, G. D., Pu, C., & Vorhees, C. V. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02107-7 · Cited by 74
Age‐Dependent Differential Responses of Monoaminergic Systems to High Doses of Methamphetamine
Kokoshka, J. M., Fleckenstein, A. E., Wilkins, D. G., & Hanson, G. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752095.x · Cited by 73
Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways
Dell’Albani, P., Kahn, M. A., Cole, R., Condorelli, D. F., Giuffrida‐Stella, A. M., & de Vellis, J. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981015)54:2 · Cited by 71
Imam, S. Z., & Ali, S. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00477.x · Cited by 68
Baldwin, H. A., Colado, M. I., Murray, T. K., Souza, R. J. D., & Green, A. R. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12847.x · Cited by 67
Intracerebral haemorrhage and vasculitis secondary to amphetamine use
Salanova, V., & Taubner, R. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.704.429 · Cited by 65
Jayanthi, S., McCoy, M. T., Ladenheim, B., & Cadet, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1124 · Cited by 65
Self-citationItzhak, Y., Martin, J. L., & Ali, S. F. (2000) · Neuroreport · doi:10.1097/00001756-200009110-00022 · Cited by 64
Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain
Kokoshka, J. M., Metzger, R. R., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00472-7 · Cited by 62
D�rries, U., Taylor, J., Xiao, Z., Lochter, A., Montag, D., & Schachner, M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960215)43:4 · Cited by 62
Involvement of ICE family proteases in apoptosis induced by reoxygenation of hypoxic hepatocytes
Shimizu, S., Eguchi, Y., Kamiike, W., Akao, Y., Kosaka, H., Hasegawa, J., Matsuda, H., & Tsujimoto, Y. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.6.g949 · Cited by 61
Amphetamines: An Update on Forensic Issues
Logan, B. K. (2001) · Journal of Analytical Toxicology · doi:10.1093/jat/25.5.400 · Cited by 60
Ricaurte, G. A., Fuller, R. W., Perry, K. W., Seiden, L. S., & Schuster, C. R. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90075-8 · Cited by 59
Kirksey, D. F., & Slotkin, T. A. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb08692.x · Cited by 59
Takaki, M., Ujike, H., Kodama, M., Takehisa, Y., Nakata, K., & Kuroda, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00615.x · Cited by 57
Cadet, J. L., Ali, S. F., & EPSTEIN, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21827.x · Cited by 57
Self-citationLackinger, D. (2001) · Mutagenesis · doi:10.1093/mutage/16.3.233 · Cited by 57
Nakayama, M., Koyama, T., & Yamashita, I. (1993) · Brain Research · doi:10.1016/0006-8993(93)91712-2 · Cited by 55
Sullivan, A. M., Opacka‐Juffry, J., Hötten, G., Pohl, J., & Blunt, S. B. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00623-x · Cited by 54
Wędzony, K., Maćkowiak, M., Fijał, K., & Gołembiowska, K. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199611)24:3 · Cited by 53
Self-citationNitric Oxide Is a Mediator of Methamphetamine (METH)‐Induced Neurotoxicity
SHENG, P., Cerruti, C., Ali, S. F., & Cadet, J. L. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17440.x · Cited by 53
Self-citationMice with Partial Deficiency of c-Jun Show Attenuation of Methamphetamine-Induced Neuronal Apoptosis
Deng, X., Jayanthi, S., Ladenheim, B., Krasnova, I. N., & Cadet, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.993 · Cited by 50
Self-citationMethamphetamine-induced dopaminergic neurotoxicity in mice
Itzhak, Y., Martin, J. L., & Ali, S. F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00257-9 · Cited by 46
Marek, G. J., Vosmer, G., & Seiden, L. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90889-j · Cited by 44
Sánchez, V., Zeini, M., Camarero, J., O’Shea, E., Boscá, L., Green, A. R., & Colado, M. I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01714.x · Cited by 39
Cadet, J. L., McCoy, M. T., & Ladenheim, B. (2002) · Synapse · doi:10.1002/syn.10074 · Cited by 38
Self-citationItzhak, Y., & Ali, S. F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04156.x · Cited by 38
Hirata, H., Asanuma, M., & Cadet, J. L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00055-2 · Cited by 37
Self-citationCallahan, B. T., Cord, B. J., Yuan, J., McCann, U. D., & Ricaurte, G. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00341.x · Cited by 36
Miller, D. B., O'Callaghan, J. P., & Ali, S. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05196.x · Cited by 36
Teuchert‐Noodt, G., & Dawirs, R. R. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90181-a · Cited by 33
Late induction of human DNA ligase I after UV-C irradiation
Montecucco, A., Savini, E., Biamonti, G., Stefanini, M., Focher, F., & Ciarrocchi, G. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.6.962 · Cited by 33
Sonsalla, P. K., Gibb, J. W., & Hanson, G. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90139-5 · Cited by 32
Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium
Schepens, P., Pauwels, A., Damme, P. V., Musuku, A., Beaucourt, L., & Selala, M. I. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70210-0 · Cited by 30
Intracerebral hemorrhage and angiographic beading following amphetamine abuse
Conci, F., D’Angelo, V., Tampieri, D. I., & Vecchi, G. L. (1988) · Neurological Sciences · doi:10.1007/bf02334412 · Cited by 27
Direct interactions of methamphetamine with the nucleus
Asanuma, M., Hayashi, T., Ordonez, S., Ogawa, N., & Cadet, J. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00128-5 · Cited by 26
Self-citationIncreased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine
Ricaurte, G. A. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90228-9 · Cited by 26
Illicit Methamphetamine: Analysis, Synthesis, and Availability
Puder, K. S., Kagan, D. V., & Morgan, J. P. (1988) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998809001564 · Cited by 23
Fukui, K., Nakajima, T., Kariyama, H., Kashiba, A., Kato, N., Tohyama, I., & Kimura, H. (1989) · Brain Research · doi:10.1016/0006-8993(89)90562-3 · Cited by 22
Itzhak, Y., Martin, J. L., & Ali, S. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05188.x · Cited by 21
Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats
Marek, G. J., Vosmer, G. L., & Seiden, L. S. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90147-a · Cited by 20
Fleckenstein, A. E., Beyeler, M. L., Jackson, J. C., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00081-2 · Cited by 19
Hotchkiss, A. J., & Gibb, J. W. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90143-0 · Cited by 18
Research works printed but not linked: 1
- Cadet J. L., 2003, Gluamate and Addiction, 201
Cited by
Sorted by citations
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Methamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381
Self-citationPaulus, M. P., Tapert, S. F., & Schuckit, M. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.761 · Cited by 369
Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 319
Metadata
- Authors
- Cadet, J. L., Jayanthi, S., & Deng, X.
- Affiliations
- National Institutes of Health (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 17
- Issue
- 13
- Pages
- 1775-1788
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2083351059
- Cited by
- 286
- References
- 212
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 10 · 2012: 14
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Institute on Drug Abuse
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, neurotoxicity, neuronal apoptosis, nerve terminal degeneration, monoaminergic systems, reactive oxygen species, transcription factors, cell death genes, endoplasmic reticulum stress, mitochondrial dysfunction, caspase activation
- MeSH terms
- Animals, Humans, Methamphetamine, Models, Biological, Nerve Degeneration, Neurons, Signal Transduction, Apoptosis, Presynaptic Terminals, Cytoprotection, Neurotoxicity Syndromes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review